ats-13-04
ats-13-02
ats-13-04
ats-13-02

ATS-13® Activity Assay

What is your testing algorithm for patients suspected of having thrombotic thrombocytopenic purpura (TTP)?

ATS-13 Activity Assay provides protocols to quantitatively measure ADAMTS-13 protease activity and determine the presence of inhibitory antibodies to ADAMTS-13 in human plasma.

ADAMTS-13 is the protease that cleaves von Willebrand Factor. Significant decreases or an absence of ADAMTS-13 activity can lead to the formation of ultra-large vWF fragments and trigger iIntravascular platelet aggregation and microthrombosis, causing the signs and symptoms of thrombotic thrombocytopenic purpura, TTP.

Quick and Easy

  • Set up in less than 10 minutes
  • Pre-diluted calibrators
  • Results in under 45 minutes

Sensitive

  • Utilizes fluorescence resonance energy transfer (FRET) technology with less test variability
  • % Activity and % Inhibition derived from a fluorescent endpoint

Research Use Only (RUO). Not for use in diagnostic procedures.

Resource Library

Our Certifications

Related Products

pipetting-lab-04

Factor VIII Antibody Screen

luminex-lab-07

PF4 Enhanced® and PF4 IgG Assay​

Upcoming Events,
Webinars & Workshops

Upcoming Event

Antibody Detection and identification: Patterns, Patience and Precision

When

June 29th 2022

Where

Virtual

Upcoming Event

Hematopoietic Stem Cell Transplantation from Unrelated Donors in Germany: Structure, Figures, Matching Guidelines, Outcomes

When

June 29th 2022

Where

Virtual

Upcoming Event

Hematopoietic Stem Cell Transplantation from Unrelated Donors in Germany: Structure, Figures, Matching Guidelines, Outcomes

When

June 30th 2022

Where

Virtual

Experience Our Virtual Lab

Seeing Beyond Limits

  • Transfuse
  • Transplant
  • Transform a Life
Immucor

5 Isnor Drive, Dartmouth. NS, Canada B3B 1M1

Call 800.565.0653 or 902.468.3992

Fax 902.468.3599

Email [email protected]